204 related articles for article (PubMed ID: 27084254)
1. Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies.
Langeberg WJ; Schoonen WM; Eisen M; Gamelin L; Stryker S
Int J Hematol; 2016 Jun; 103(6):655-64. PubMed ID: 27084254
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.
Doobaree IU; Nandigam R; Bennett D; Newland A; Provan D
Eur J Haematol; 2016 Oct; 97(4):321-30. PubMed ID: 27199203
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes.
Goncalves I; Lewis C; Grainger B; Dring R; Lee N; Pasricha SR; Szer J; Mason K
Res Pract Thromb Haemost; 2024 Jan; 8(1):102342. PubMed ID: 38444612
[TBL] [Abstract][Full Text] [Related]
4. Is ITP a thrombophilic disorder?
Rodeghiero F
Am J Hematol; 2016 Jan; 91(1):39-45. PubMed ID: 26547507
[TBL] [Abstract][Full Text] [Related]
5. Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.
Ekstrand C; Linder M; Baricault B; Lafaurie M; Sailler L; Lapeyre-Mestre M; Kieler H; Moulis G; Bahmanyar S
Thromb Res; 2019 Jun; 178():124-131. PubMed ID: 31026663
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study.
Le Guenno G; Guieze R; Audia S; Khellaf M; Michel M; Bonnotte B; Ruivard M; Godeau B
Intern Med J; 2019 Sep; 49(9):1154-1162. PubMed ID: 30816621
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.
Michel M; Wasser J; Godeau B; Aledort L; Cooper N; Tomiyama Y; Khellaf M; Wang X
Ann Hematol; 2015 Dec; 94(12):1973-80. PubMed ID: 26341755
[TBL] [Abstract][Full Text] [Related]
9. Thrombosis in patients with primary chronic immune thrombocytopenia.
Nørgaard M
Thromb Res; 2012 Oct; 130 Suppl 1():S74-5. PubMed ID: 23026671
[TBL] [Abstract][Full Text] [Related]
10. Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.
Watanabe R; Tabayashi T; Tomikawa T; Sagawa M; Anan-Nemoto T; Kimura Y; Takahashi Y; Tokuhira M; Otaki S; Oi H; Sawano M; Sugiyama S; Kizaki M
Int J Hematol; 2017 Jan; 105(1):100-103. PubMed ID: 27709451
[TBL] [Abstract][Full Text] [Related]
11. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review.
Abrahamson PE; Hall SA; Feudjo-Tepie M; Mitrani-Gold FS; Logie J
Eur J Haematol; 2009 Aug; 83(2):83-9. PubMed ID: 19245532
[TBL] [Abstract][Full Text] [Related]
12. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.
Ruggeri M; Tosetto A; Palandri F; Polverelli N; Mazzucconi MG; Santoro C; Gaidano G; Lunghi M; Zaja F; De Stefano V; Sartori R; Fazi P; Rodeghiero F;
J Thromb Haemost; 2014 Aug; 12(8):1266-73. PubMed ID: 24942752
[TBL] [Abstract][Full Text] [Related]
14. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
Mazza P; Minoia C; Melpignano A; Polimeno G; Cascavilla N; Di Renzo N; Specchia G
Ann Hematol; 2016 Jan; 95(2):239-44. PubMed ID: 26596973
[TBL] [Abstract][Full Text] [Related]
15. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.
Rodeghiero F; Stasi R; Giagounidis A; Viallard JF; Godeau B; Pabinger I; Cines D; Liebman H; Wang X; Woodard P
Eur J Haematol; 2013 Nov; 91(5):423-36. PubMed ID: 23927437
[TBL] [Abstract][Full Text] [Related]
17. Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia.
Boyle S; White RH; Brunson A; Wun T
Blood; 2013 Jun; 121(23):4782-90. PubMed ID: 23637127
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database.
Yong M; Schoonen WM; Li L; Kanas G; Coalson J; Mowat F; Fryzek J; Kaye JA
Br J Haematol; 2010 Jun; 149(6):855-64. PubMed ID: 20377590
[TBL] [Abstract][Full Text] [Related]
19. A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.
Steurer M; Quittet P; Papadaki HA; Selleslag D; Viallard JF; Kaiafa G; Janssens A; Kozak T; Wadenvik H; Schoonen M; Belton L; Kreuzbauer G
Eur J Haematol; 2017 Feb; 98(2):112-120. PubMed ID: 27557853
[TBL] [Abstract][Full Text] [Related]
20. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
Weber E; Moulis G; Mahévas M; Guy C; Lioger B; Durieu I; Hunault M; Ramanantsoa M; Royer B; Default A; Pérault-Pochat MC; Moachon L; Bernard N; Bardy G; Jonville-Bera AP; Geniaux H; Godeau B; Cathébras P
Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
